Delta Global Management LP raised its position in shares of Centene Corporation (NYSE:CNC – Free Report) by 96.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 78,691 shares of the company’s stock after acquiring an additional 38,640 shares during the period. Delta Global Management LP’s holdings in Centene were worth $2,808,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in CNC. Addison Advisors LLC lifted its position in shares of Centene by 455.6% during the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after purchasing an additional 606 shares during the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in Centene in the 3rd quarter valued at approximately $27,000. WPG Advisers LLC increased its position in Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after buying an additional 282 shares during the period. Bogart Wealth LLC lifted its holdings in shares of Centene by 11,011.1% during the third quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after buying an additional 991 shares during the last quarter. Finally, Ameriflex Group Inc. grew its stake in shares of Centene by 152.5% in the third quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock worth $36,000 after acquiring an additional 610 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
CNC has been the subject of several research analyst reports. TD Cowen upped their target price on shares of Centene from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Wednesday, February 11th. Wall Street Zen lowered shares of Centene from a “buy” rating to a “hold” rating in a research report on Sunday, February 15th. Jefferies Financial Group cut their price objective on shares of Centene from $43.00 to $37.00 and set a “hold” rating for the company in a research report on Friday, February 13th. Argus upgraded shares of Centene to a “hold” rating in a research note on Monday, February 9th. Finally, Morgan Stanley boosted their price target on Centene from $38.00 to $45.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 4th. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $42.06.
Centene Stock Down 0.3%
Shares of NYSE CNC opened at $34.47 on Monday. Centene Corporation has a 52-week low of $25.08 and a 52-week high of $66.03. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.10 and a current ratio of 1.10. The business has a fifty day moving average of $42.81 and a two-hundred day moving average of $38.46. The stock has a market cap of $16.95 billion, a PE ratio of -2.53, a PEG ratio of 0.76 and a beta of 0.48.
Centene (NYSE:CNC – Get Free Report) last posted its earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, topping the consensus estimate of ($1.22) by $0.03. The business had revenue of $49.73 billion for the quarter, compared to analyst estimates of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The firm’s quarterly revenue was up 21.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, equities research analysts expect that Centene Corporation will post 6.86 earnings per share for the current fiscal year.
About Centene
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Read More
- Five stocks we like better than Centene
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
